真实世界喜炎平注射液治疗儿童肺炎联合用药特征研究

doi:10.19803/j.1672-8629.2022.01.10

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (1): 47-51.
DOI: 10.19803/j.1672-8629.2022.01.10

• 真实世界老年/儿童患者应用中成药的现状研究专栏 • 上一篇下一篇

真实世界喜炎平注射液治疗儿童肺炎联合用药特征研究

苏鑫鑫¹, 李利寻¹, 王志飞^1#, 谢雁鸣^1,*, 王淇²

¹中国中医科学院中医临床基础医学研究所,北京 100700;
²中国人民大学统计学院,北京 100872

收稿日期:2021-04-19 出版日期:2022-01-15 发布日期:2022-01-20
通讯作者: ^*谢雁鸣,女,首席研究员·博导,中医临床评价方法。E-mail：ktzu2018@163.com。^#为共同通信作者。
作者简介:苏鑫鑫,女,本科,中成药上市后评价。
基金资助:
国家重点研发计划（2018YFC1707410）

Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia

SU Xinxin¹, LI Lixun¹, WANG Zhifei^1#, XIE Yanming^1,*, WANG Qi²

¹Institute of Basic Research in Clinical Medicine, China Academy of Chinese Sciences, Beijing 100700, China;
²School of statistics, Renmin University of China, Beijing 100872, China

Received:2021-04-19 Online:2022-01-15 Published:2022-01-20

摘要/Abstract

摘要： 目的分析真实世界中喜炎平注射液联合用药治疗肺炎患儿的用药特征。方法基于2006年12月1日至2016年6月30日全国29家三级甲等医院信息管理系统（HIS）数据库和实验室（检验科）信息系统（LIS）数据库,采用Apriori算法建立模型和Clementine 12.0进行关联分析,对使用喜炎平注射液的35 233例患儿人群特征和联合用药情况进行分析。结果患儿年龄0~3岁（82.83%）占比最大;真实世界中儿童人群使用喜炎平注射液多应用于一般病情;住院天数4~14 d占比最大;喜炎平注射液静脉单次每日给药剂量50~100 mg占比最大;主要用于西医诊断为支气管肺炎,中医诊断主病肺炎喘咳病,主证痰热、风热;喜炎平注射液一般联合氨溴索（美舒咳）黏液溶解药,布地奈德皮质甾体激素类,沙丁胺醇选择性β2-肾上腺素受体促效药,异丙托溴铵抗胆碱能药使用最常见。结论在治疗儿童肺炎患者时常用喜炎平注射液与黏液溶解药、皮质甾体激素类、选择性β2-肾上腺素受体促效药和抗胆碱能药类化学药品联合使用,为临床合理使用喜炎平注射液提供参考。

关键词: 喜炎平注射液, 儿童患者, 真实世界, 联合用药, 临床治疗

Abstract: Objective To analyze the medication characteristics of Xiyanping injection combined in the treatment of children with pneumonia in the real world. Methods Based on HIS and LIS database of hospitalized patients from 29 hospitals in China from December 1, 2006 to June 30, 2016, the Apriori algorithm was conducted to establish the model and clementine 12.0 was conducted to analyze the characteristics and combination medication of 35 233 children who received Xiyanping injection with pneumonia. Results Children aged 0~3 years (82.83%) accounted for the largest proportion; In the real world, Xiyanping injection is mainly used for children with general conditions; The number of days in hospital was 4~14 days; For Xiyanping injection, the single intravenous dose per day was 50~100 mg; The main diagnosis of Western medicine was bronchial pneumonia, and the main diagnosis of Traditional Chinese medicine was pneumonia, asthma and cough, and the main syndromes were phlegm-heat and wind-heat; Xiyanping injection is generally combined with ambroxol (methusol) mucus dissolver, budesonide corticosteroid hormone, salbutamol selective β2-adrenergic receptor stimulant, and ipratropium bromide anticholinergic drug. Conclusion Xiyanping injection is often used in combination with mucolysis drugs, corticosteroid hormones, selective β2-adrenergic receptor promoters and anticholinergic chemicals in the treatment of children with pneumonia to provide a reference for the rational use of Xiyanping injection in clinical practice.

Key words: Xiyanping injection, children, real-world, combination drug use, clinical treatment

中图分类号:

R974
R285.6

苏鑫鑫, 李利寻, 王志飞, 谢雁鸣, 王淇. 真实世界喜炎平注射液治疗儿童肺炎联合用药特征研究[J]. 中国药物警戒, 2022, 19(1): 47-51.

SU Xinxin, LI Lixun, WANG Zhifei, XIE Yanming, WANG Qi. Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 47-51.

参考文献

[1] SU X.Pharmacological effects and clinical research progress of andrographis and its preparations[J]. Heilongjiang Science and Technology Information(黑龙江科技信息), 2015(9): 11.
[2] ZHU L, CHEN C, WU XQ.Application status of Xiyanping injection in the field of pediatrics[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine(中国中西医结合儿科学), 2020, 12(1): 12-16.
[3] LIANG M.Immune mechanism and treatment progress of children with refractory mycoplasma pneumoniae pneumonia[J]. Chinese and Foreign Medical Research(中外医学研究), 2017, 15(15): 161-163.
[4] JIA CX.Efficacy of Xiyanping in the treatment of children with bronchopneumonia[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2020, 13(7): 33-34.
[5] WU H.The clinical study of Xiyanping injection combined with azithromycin in the treatment of mycoplasma pneumoniae pneumonia in children[J]. Chinese Journal of Modern Drug Application(中国现代药物应用), 2020, 14(20): 115-116.
[6] LI L, HAN F.Study on medication rule of traditional Chinese medicine for pediatric pneumonia based on data mining[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease(实用心脑肺血管病杂志), 2020, 28(11): 109-113.
[7] WEI CH.Clinical distribution and drug resistance analysis of strep-tococcus pneumoniae in children in Foshan area[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2017, 10(18): 83-85.
[8] HUANG YQ.Clinical effect of integrated traditional Chinese and western medicine in the treatment of pediatric pneumonia[J]. Nei Mongol Journal of Traditional Chinese Medicine(内蒙古中医药), 2020, 39(10): 44-45.
[9] YANG J.Clinical effect of integrated traditional Chinese and western medicine on mycoplasma pneumonia in children[J]. Clinical Research and Practice(临床医学研究与实践), 2018, 3(17): 126-127.
[10] AN L, HAN Y, ZHANG J, et al. Effect analysis of infantile hand foot and mouth disease treated with interferon combined with Xiyanping injection[J]. China Rural Health(中国农村卫生), 2019, 11(5): 71, 73.
[11] CHEN XY, MA JH.Clinical study of Xiyanping injection in the treatment of children with bacterial lower respiratory tract infection[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine(中国中西医结合儿科学), 2018, 10(6): 479-481.
[12] CHEN XC.Comparison of the efficacy of Xiyanping and Ribavirin in improving the clinical symptoms of upper respiratory tract infection in emergency patients[J]. Anti-Infectious Pharmacy(抗感染药学), 2019, 16(4): 699-700.
[13] WANG JY, ZHU XT.Efficacy of Xiyanping injection combined with ambroxol atomization in the treatment of 46 children with bronchial pneumonia[J]. The Medical Forum(基层医学论坛), 2013, 17(17): 2218-2219.
[14] ZHAN WJ.Effect of Xiyanping combined with budesonide aerosol inhalation on children with bronchial asthma[J]. Chinese Journal of Medical Device(医疗装备), 2017, 30(5): 130.
[15] DAI YH, WANG L.The clinical treatment effect of Chinese and western medicine combining to treat mycombinolin pneumonia in children is discussed[J]. Smart Healthcare(智慧健康), 2019, 5(11): 103-104.
[16] WANG DL.Clinical effect observation of the treatment of mycoplasma pneumoniae pneumonia in children with integrated traditional Chinese and western medicine[J]. Guangming Journal of Chinese Medicine(光明中医), 2013, 28(8): 1721-1722.

真实世界喜炎平注射液治疗儿童肺炎联合用药特征研究

Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	史卜文, 李利寻, 谢雁鸣, 王志飞, 王淇. 真实世界喜炎平注射液治疗3846例细菌性肠道感染患者临床用药特征分析[J]. 中国药物警戒, 2023, 20(9): 1017-1021.
[2]	严亦舒, 赵岩, 卢天公, 孙震晓. 大黄素-8-O-β-D-葡萄糖苷联合紫杉醇抑制人乳腺癌细胞活力及侵袭转移的研究[J]. 中国药物警戒, 2023, 20(7): 728-734.
[3]	王淑伟, 殷进军, 王冰, 宋彩萍, 杨福俊. 阿昔替尼片联合特瑞普利单抗治疗晚期肾癌致视网膜中央动脉阻塞1例分析[J]. 中国药物警戒, 2023, 20(7): 825-828.
[4]	罗琼, 李盟, 李光耀, 何彦春, 周祖山, 孙鑫, 刘成海. 635例类风湿性关节炎患者应用雷公藤制剂所致肝损伤的中医证候及联合用药特点[J]. 中国药物警戒, 2023, 20(5): 500-504.
[5]	赵燕, 刘文博, 赵一飞, 李栋, 郑立佳, 宋雅娜, 赵玉娟, 董放. 患者登记研究应用于医疗器械监管科学的实践研究与思考[J]. 中国药物警戒, 2023, 20(4): 423-427.
[6]	杜莹, 谢雁鸣, 王连心, 耿洪娇, 李向杰. 真实世界连花清瘟胶囊（颗粒）适应证人群临床特征及联合用药分析[J]. 中国药物警戒, 2023, 20(3): 296-300.
[7]	杜莹, 赵晓晓, 谢雁鸣, 余小康. 基于真实世界使用榄香烯乳状注射液影响肝功能的倾向性评分分析[J]. 中国药物警戒, 2023, 20(2): 191-195.
[8]	王嘉熙, 郭代红, 张博, 李伯妍, 郭海丽. 116097例氟比洛芬酯用药人群的急性肾损伤自动监测研究及危险因素分析[J]. 中国药物警戒, 2023, 20(2): 201-205.
[9]	姚鑫, 葛秋格, 李亚敏, 王一帆, 李媛媛, 刘志强. 2018~2022年某院新型抗肿瘤药物消化系统不良反应分析[J]. 中国药物警戒, 2023, 20(11): 1273-1278.
[10]	吴昀效, 于玥琳, 王胜锋, 孙凤, 孟若谷, 詹思延. 真实世界数据在疫苗上市后安全性主动监测中适用性评价分析[J]. 中国药物警戒, 2023, 20(10): 1081-1089.
[11]	孙静, 赵荣华, 包蕾, 郭姗姗, 耿子涵, 李舒冉, 徐英莉, 崔晓兰. 疏风解毒胶囊联合左氧氟沙星治疗多重耐药铜绿假单胞菌感染性小鼠肺炎的作用研究[J]. 中国药物警戒, 2023, 20(1): 52-56.
[12]	苏鑫鑫, 赵晓晓, 谢雁鸣. 榄香烯乳注射液治疗肝癌患者的真实世界联合用药分析[J]. 中国药物警戒, 2022, 19(9): 929-934.
[13]	黄艳丽, 谢雁鸣, 王连心, 孙粼希, 刘峘, 庄鋆妮. 真实世界老年患者使用刺五加注射液的临床分析[J]. 中国药物警戒, 2022, 19(9): 935-939.
[14]	赵晓晓, 谢雁鸣, 王连心. 真实世界榄香烯乳状注射液治疗肺癌临床应用特征研究[J]. 中国药物警戒, 2022, 19(9): 940-946.
[15]	谭畅, 赵晓晓, 支英杰, 王连心, 谢雁鸣. 榄香烯乳状注射液治疗脑瘤人群临床特征及联合用药的复杂网络分析[J]. 中国药物警戒, 2022, 19(9): 947-953.